hotspot -WSS

hotspot

author：hotspot 2025-10-01 20:14:03 - browse：9441

BIO is proceeding with a restructuring after its new CEO took over. Lane Turner/The Boston Globe

WASHINGTON — The Biotechnology Innovation Organization on Monday is announcing a significant restructuring accompanied by a shakeup, according to five sources familiar with the planning.

A few senior leaders are expected to depart as part of the reorganization. Chief Science Officer Cartier Esham, Chief Public Affairs and Marketing Officer Rich Masters, and Chief Policy Officer John Murphy are expected to leave, four sources said.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Prior authorization reform is both possible and imperative

WSS

High breast density mammograms need follow

Update the Apgar Score to remove skin color

Listen: Biogen's situation, Wegovy's risks, & biotech insider trading

5 important ways Henrietta Lacks changed medical science

Infectious disease expert Jeanne Marrazzo assumes Fauci role

Adults seen as increasingly susceptible to measles

explore

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

focus

Novavax promises a turnaround & Lilly roils the obesity market

Wildfire pollution widens asthma inequities on Long Island

How one medical school became remarkably diverse

‘Oppenheimer’ and the risks of AI in health care

Medical leaders decry Supreme Court decision on affirmative action

Infectious disease expert Jeanne Marrazzo assumes Fauci role

Supreme Court strikes down use of affirmative action

Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal

What does generative AI mean for health care? We asked experts

Mass General, Mayo Clinic look to monetize custom

focus

Medicare bonuses could stop drug shortages under Senate plan

Flu vaccine reformulation won't be easy, manufacturers warn

Printout prescription drug information shouldn’t go digital

To bolster infectious disease surveillance, genomics powerhouses team up

Mass General, Mayo Clinic look to monetize custom

Microsoft launches AI tool for clinical documentation through Epic

Wikipedia

focus

focus

hotspot